Allison Marie Winter MD

PubMed

• Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study.
  Matthew S Davids, Asher Chanan-Khan, Sikander Ailawadhi, Vladimir Ivanov, Ganna Usenko
  Med. 2025-12-12
• 1 citations
  Carfilzomib in combination with R-CHOP for initial treatment of patients with non-germinal center diffuse large B-cell lymphoma: a multicenter, single arm, phase 1/2 s...
  Brian T Hill, Pallawi Torka, Francisco Hernandez-Ilizaliturri, Robert Dean, Deepa Jagadeesh
  Leukemia & Lymphoma. 2025-09-01
• Feasibility of Bruton's Tyrosine Kinase Inhibitor Discontinuation in Chronic Lymphocytic Leukemia: The Patient Perspective.
  Deborah M Stephens, Chris Stewart, Liza Avruch, Catherine C Coombs, Alexey Danilov
  Clinical Lymphoma, Myeloma & Leukemia. 2025-09-01

Abstracts/Posters

• Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular Therapies
  Allison M. Winter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis
  Allison M. Winter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Comparative Outcomes of Relapsed Follicular Lymphoma Patients Treated with Novel Agents: A Multi-Center Analysis 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019